Thomas Blinka

    • Obtained the first US patents covering combination HIV therapies for Gilead Sciences 

    • Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb 

    • Global cross-license achieved for Gevo in long-running biofuels patent case 

    • Kyle Bass’ attacks on multiple Horizon Pharma patents is blocked 

    • Vitae Pharmaceuticals Completes Initial Public Offering  

    • Cara Therapeutics $55 Million Initial Public Offering 

    • AcelRx Pharmaceuticals in Public Offering 

    • Otsuka $825 Million Collaboration Agreement to Develop Alzheimer's Drug